Wednesday, 30 July 2025
The production of vitamin C in Jiangshan was completely stopped in mid-May 2023 dsm-firmenich has recently sold its complete equity interest in DSM Jiangshan Pharmaceutical to Jingjiang Cosfocus Health Technology…
The production of vitamin C in Jiangshan was completely stopped in mid-May 2023
dsm-firmenich has recently sold its complete equity interest in DSM Jiangshan Pharmaceutical to Jingjiang Cosfocus Health Technology China. In June 2023, dsm-firmenich announced its plan to restructure its vitamin assets to reduce significant costs. As a part of this plan, the Xinghuo vitamin B6 plant in China was shut down, and the focus was shifted solely to vitamin C activities, exclusively on Quali-C from Dalry (UK).
The production of vitamin C in Jiangshan was completely stopped in mid-May 2023. The company is currently exploring various options for the Jiangshan site, including partnerships or repurposing manufacturing assets. However, the terms of the transaction have not been disclosed.
Jul 30, 2025 | Company News
Jul 30, 2025 | Beverages
Jul 29, 2025 | Cultured Meat
Jul 21, 2025 | Food Safety and Testing
Jul 16, 2025 | Company News
Jul 30, 2025 | Company News
Jul 30, 2025 | Food
Jul 30, 2025 | Food Security